- Home
- FBRX vs TCMD Comparison
FBRX vs TCMD Comparison
Compare FBRX & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | TCMD |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 533.5M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FBRX | TCMD |
|---|---|---|
| Price | $17.84 | $26.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $67.00 | $36.00 |
| AVG Volume (30 Days) | ★ 225.5K | 188.3K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | 17.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.12 | $9.42 |
| 52 Week High | $35.80 | $37.77 |
Technical Indicators
Market Signals| Indicator | FBRX | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 59.28 |
| Support Level | $17.33 | $25.79 |
| Resistance Level | $22.84 | $27.67 |
| Average True Range (ATR) | 1.34 | 0.88 |
| MACD | 0.34 | 0.11 |
| Stochastic Oscillator | 45.44 | 89.47 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.